Drug Topics June 2024

Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.

Skin complications are common in patients with diabetes, but pharmacists can recommend several easy measures to help.

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.

One of the biggest issues pharmacists are watching is the Medicare Part D redesign and copay smoothing policy.

The specialty drug market has exploded in the last few decades.

As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.

Data from 2024 are being used as a way to predict what changes may be on the way for 2025.